<?xml version='1.0' encoding='utf-8'?>
<document id="19280525"><sentence text="Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions." /><sentence text="African green monkeys (vervets) have been proposed as an alternate species that might allow improved access and provide high-quality pharmacokinetic results comparable with other primates" /><sentence text=" However, no oral data are available in vervets to evaluate cross-species predictive performance" /><sentence text=" Therefore, this study was conducted to evaluate the use of the vervet to predict human oral pharmacokinetics and drug interactions" /><sentence text=" Oral pharmacokinetic studies were conducted in the vervet for eight compounds: phenytoin, moxifloxacin, erythromycin, lidocaine, propranolol, ciprofloxacin, metroprolol, and prednisolone"><entity charOffset="80-89" id="DDI-PubMed.19280525.s5.e0" text="phenytoin" /><entity charOffset="91-103" id="DDI-PubMed.19280525.s5.e1" text="moxifloxacin" /><entity charOffset="105-117" id="DDI-PubMed.19280525.s5.e2" text="erythromycin" /><entity charOffset="119-128" id="DDI-PubMed.19280525.s5.e3" text="lidocaine" /><entity charOffset="130-141" id="DDI-PubMed.19280525.s5.e4" text="propranolol" /><entity charOffset="143-156" id="DDI-PubMed.19280525.s5.e5" text="ciprofloxacin" /><entity charOffset="158-169" id="DDI-PubMed.19280525.s5.e6" text="metroprolol" /><entity charOffset="175-187" id="DDI-PubMed.19280525.s5.e7" text="prednisolone" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e0" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e1" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e0" e2="DDI-PubMed.19280525.s5.e7" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e1" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e1" e2="DDI-PubMed.19280525.s5.e7" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e2" e2="DDI-PubMed.19280525.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e2" e2="DDI-PubMed.19280525.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e2" e2="DDI-PubMed.19280525.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e2" e2="DDI-PubMed.19280525.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e2" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e2" e2="DDI-PubMed.19280525.s5.e7" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e3" e2="DDI-PubMed.19280525.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e3" e2="DDI-PubMed.19280525.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e3" e2="DDI-PubMed.19280525.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e3" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e3" e2="DDI-PubMed.19280525.s5.e7" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e4" e2="DDI-PubMed.19280525.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e4" e2="DDI-PubMed.19280525.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e4" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e4" e2="DDI-PubMed.19280525.s5.e7" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e5" e2="DDI-PubMed.19280525.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e5" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e5" e2="DDI-PubMed.19280525.s5.e7" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e6" e2="DDI-PubMed.19280525.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19280525.s5.e6" e2="DDI-PubMed.19280525.s5.e7" /></sentence><sentence text=" To assess drug-drug interactions, co-administration experiments were conducted with ketoconazole and either propranolol or erythromycin"><entity charOffset="85-97" id="DDI-PubMed.19280525.s6.e0" text="ketoconazole" /><entity charOffset="109-120" id="DDI-PubMed.19280525.s6.e1" text="propranolol" /><entity charOffset="124-136" id="DDI-PubMed.19280525.s6.e2" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.19280525.s6.e0" e2="DDI-PubMed.19280525.s6.e0" /><pair ddi="false" e1="DDI-PubMed.19280525.s6.e0" e2="DDI-PubMed.19280525.s6.e1" /><pair ddi="false" e1="DDI-PubMed.19280525.s6.e0" e2="DDI-PubMed.19280525.s6.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s6.e1" e2="DDI-PubMed.19280525.s6.e1" /><pair ddi="false" e1="DDI-PubMed.19280525.s6.e1" e2="DDI-PubMed.19280525.s6.e2" /></sentence><sentence text=" In general, the vervet provided similar predictivity for human oral exposure as cynomolgus or rhesus monkeys" /><sentence text=" In all non-human primates, human exposure to phenytoin would be over-predicted, and erythromycin, lidocaine, and propranolol under-predicted, with good predictivity for the other compounds studied"><entity charOffset="46-55" id="DDI-PubMed.19280525.s8.e0" text="phenytoin" /><entity charOffset="85-97" id="DDI-PubMed.19280525.s8.e1" text="erythromycin" /><entity charOffset="99-108" id="DDI-PubMed.19280525.s8.e2" text="lidocaine" /><entity charOffset="114-125" id="DDI-PubMed.19280525.s8.e3" text="propranolol" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e0" e2="DDI-PubMed.19280525.s8.e0" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e0" e2="DDI-PubMed.19280525.s8.e1" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e0" e2="DDI-PubMed.19280525.s8.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e0" e2="DDI-PubMed.19280525.s8.e3" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e1" e2="DDI-PubMed.19280525.s8.e1" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e1" e2="DDI-PubMed.19280525.s8.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e1" e2="DDI-PubMed.19280525.s8.e3" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e2" e2="DDI-PubMed.19280525.s8.e2" /><pair ddi="false" e1="DDI-PubMed.19280525.s8.e2" e2="DDI-PubMed.19280525.s8.e3" /></sentence><sentence text=" Furthermore, in the vervet, ketoconazole co-administration resulted in a six-fold increase in exposure to erythromycin, demonstrating proof of concept for drug-drug interaction screening"><entity charOffset="29-41" id="DDI-PubMed.19280525.s9.e0" text="ketoconazole" /><entity charOffset="107-119" id="DDI-PubMed.19280525.s9.e1" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.19280525.s9.e0" e2="DDI-PubMed.19280525.s9.e0" /><pair ddi="false" e1="DDI-PubMed.19280525.s9.e0" e2="DDI-PubMed.19280525.s9.e1" /></sentence><sentence text=" These data support further exploration of the vervet as an alternate primate species for use in preclinical pharmacokinetic screening" /><sentence text="" /></document>